Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes

Fig. 2

Comparison of CRA progression between group A and group B. Group B (yellow line) showed significantly reduced perilesional CRA progression compared with group A (blue line). (A) Perilesional CRA progression after treatment. (B) Patchy extralesional CRA progression after treatment. Error bars refer to the standard error of the mean (SEM)

Back to article page